SCHEMBL6539723

SCHEMBL6539723

COc1ccc(-c2oc(C(=O)N(C)OC)nc2-c2ccc(OCc3ccccc3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 4/20 0.47
LMNA P02545 3/20 0.45
ALDH1A1 P00352 2/20 0.45
HTT P42858 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MAOB P27338 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NPC1 O15118 1/20 0.43
ATM Q13315 1/20 0.43
ANO1 Q5XXA6 1/20 0.43
GSK3B P49841 1/20 0.43
BACE1 P56817 1/20 0.43
NR4A2 P43354 2/20 0.43
RXRA P19793 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6235969 1.00 PPARD (0.47) PPARDLMNAALDH1A1HTTNPSR1
SCHEMBL6232912 0.90 MEN1 (0.48) PPARDLMNAALDH1A1L3MBTL1SMN1; SMN2
SCHEMBL6539638 0.88 PPARD (0.47) PPARDLMNAALDH1A1HTTNPSR1
SCHEMBL6229619 0.87 NR4A2 (0.58) PPARDLMNAALDH1A1HTTNPSR1
SCHEMBL6539397 0.87 NR4A2 (0.44) PPARDLMNAALDH1A1HTTSMN1; SMN2
SCHEMBL6207458 0.85 PPARD (0.49) PPARDLMNAALDH1A1HTTNPSR1
SCHEMBL6539618 0.84 PPARD (0.48) PPARDLMNAALDH1A1HTTNPSR1
SCHEMBL6539702 0.83 PPARD (0.49) PPARDLMNAALDH1A1HTTNPSR1
SCHEMBL6539225 0.83 PPARD (0.49) PPARDLMNAALDH1A1HTTNPSR1
SCHEMBL6539399 0.82 PPARD (0.47) PPARDLMNAALDH1A1HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157891-A1 Inhibitor of cox FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157891-A1 Inhibitor of cox PTGS1, PTGS2, PTGES2 PPARD 1747/4885LMNA 2620/4885ALDH1A1 163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.